3-(2,4-dichlorophenyl)prop-2-ynoic acid, 95.0%, 10g

6-bromo-2-methyl-2H-indazole-3-carboxylic acid, 95.0%, 500mg

Sodium 2-amino-2-benzamidoacetate, 95.0%, 5g

7-Amino-4-methyl-1H-indole-3-carbonitrile, 95.0%, 1g

(2S,4R)-ETHYL-4-METHYLPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE, 95.0%, 250mg

(5-Chloro-2-cyanophenyl)boronic acid, 95.0%, 5g

4-Chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine, 95%, 250mg

4-METHOXY-N-METHYLBENZENESULFONAMIDE, 95.0%, 5g

Sodium N-Lauroylsarcosinate [for Biochemical Research]>98.0%(N)25g

(3R,4R)-1-benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylic acid hydrochloride, 95%, 1g

3-Amino-N-tert-butyl-benzenesulfonamide, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-5, 15 m, 0,32 mm, 1,00 µm, 1 pièce(s)

HSA-L1-L11vial